Login / Signup

Transient and DNA-free in vivo CRISPR/Cas9 genome editing for flexible modeling of endometrial carcinogenesis.

Raúl NavaridasMaria Vidal-SabanésAnna Ruiz-MitjanaAida Perramon-GüellCristina Megino-LuqueDavid Llobet-NavasXavier Matias-GuiuJoaquim EgeaMario EncinasLídia BardiaJulien ColombelliXavier Dolcet
Published in: Cancer communications (London, England) (2023)
Keyphrases
  • genome editing
  • crispr cas
  • circulating tumor
  • cell free
  • single molecule
  • cerebral ischemia
  • endometrial cancer
  • nucleic acid
  • circulating tumor cells
  • solid state
  • brain injury
  • subarachnoid hemorrhage